2A Pharma ApS: Financial statements 2023
CVR: 39391597
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 159,246 and a net result of DKK -42,621 compared with DKK -1,523,981 the year before. Equity in the 2023 report amounted to DKK 671,868. The solvency ratio was 80.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 159,246
- Profit/Loss
- DKK -42,621
- Equity
- DKK 671,868
- Total Assets
- DKK 834,426
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 159 t. | -43 t. | 672 t. | 2 |
| 2022 | - | -210 t. | -1.5 mio. | -586 t. | 2 |
| 2021 | - | 1.9 mio. | 272 t. | 938 t. | 2 |
| 2020 | - | 2.1 mio. | 322 t. | 667 t. | 3 |
| 2019 | - | 1.5 mio. | -81 t. | 344 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
2A Pharma ApS has published its annual report for 2022. Gross profit came to DKK -210,110, and the net result was DKK -1,523,981.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.